Dr. Blumenthal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10755 Falls Road
Pavilion I Ste 360
Lutherville, MD 21093Phone+1 443-997-0270Fax+1 410-367-2448
Summary
- I am the Director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. I was Co-Chair of the AHA/ACC Subcommittee that oversaw the Hypertension, Cholesterol, Risk Assessment and Primary Prevention of Cardiovascular Disease Guidelines from 2015-2019.
Education & Training
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2002
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1988 - 1992
- Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1988
- Weill Cornell MedicineClass of 1985
- Johns Hopkins UniversityB.A., Natural Sciences, 1977 - 1981
Certifications & Licensure
- MD State Medical License 1986 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Top Doctors:Baltimore Area Castle Connolly, 2012-2021
- America's Top Doctors Castle Connolly, 2001-2021
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Join now to see all
Publications & Presentations
PubMed
- 75 citationsCardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study.Roberta Florido, Natalie R Daya, Chiadi E Ndumele, Silvia Koton, Stuart D Russell
Journal of the American College of Cardiology. 2022-07-05 - 1143 citationsInterpretation of the evidence for the efficacy and safety of statin therapy.Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent
Lancet. 2016-11-19 - 248 citationsGender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort.Susan G. Lakoski, Mary Cushman, Michael H. Criqui, Tatjana Rundek, Roger S. Blumenthal
American Heart Journal. 2006-09-01
Journal Articles
- Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsSeamus P Whelton, John W Mcevoy, Matthew Budoff, Khurram Nasir, Roger S Blumenthal, Michael J Blaha, JAMA Cardiology
- Clinical Research Adiposity and Incident Heart Failure and Its Subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)Roger S Blumenthal, Erin D Michos, Mary Cushman, Matthew A Allison, Kavita Sharma, Michael H Criqui, ScienceDirect
- Review Article Communication Issues in Nutritional Observational ResearchMichael J Blaha, Roger S Blumenthal, John W McEvoy, ScienceDirect
- Join now to see all
Lectures
- Results from EVAPORATE Trial Suggest That Cardioprotective Benefits of Eicosapentaenoic Acid (EPA) Are Related to Plaque Reduction and StabilizationThe Johns Hopkins University School of Medicine, Baltimore, Maryland - 6/28/2012
- Facts or Alternate Facts: A Case-Based Deep Dive Into the Recently Released Prevention Guidelines2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Late-Breaking Clinical Trials2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Join now to see all
Authored Content
- A Remote Technology-Enabled, Algorithm-Guided Program to Improve Health Equity in Hypertension and LDL-C ManagementFebruary 2022
- Cardiovascular Health in Early Life: Sign of What's to Come?October 2021
- Identifying the Roadblocks to Engagement of Women in Clinical TrialsOctober 2021
- Statin Therapy Allocation in Intermediate Risk PopulationSeptember 2021
- Update in Prevention: 2021 Canadian Cardiovascular Society Dyslipidemia GuidelinesSeptember 2021
- Use of Cardiac CT to Improve Medical Management in Adults with Diabetes: CAC in the Asymptomatic Patient (Part I)November 2020
- Approaching Statin Therapy in Adults with and Without DiabetesOctober 2020
- CCTA as a Tool for Prevention in Patients with Stable Chest PainSeptember 2020
- Outcomes of Acute Myocardial Infarction Hospitalizations During the COVID-19 PandemicAugust 2020
- Outcomes of Acute Myocardial Infarction Hospitalizations During the COVID-19 PandemicAugust 2020
- Comparison of Dietary and Exercise Recommendations on Both Sides of the AtlanticAugust 2020
- Non-Invasive Assessment of Myocardial ViabilityAugust 2020
- Bempedoic Acid for LDL-C Lowering: What Do We Know?August 2020
- Determining the Role of Coronary Artery Disease Severity Measured by Coronary CTA in ASCVD Risk ManagementJuly 2020
- Continuing Preventive Care During the COVID-19 Pandemic: Discussion of Recent ASPC RecommendationsJuly 2020
- Continuing Preventive Care During the COVID-19 Pandemic: Discussion of Recent ASPC RecommendationsJuly 2020
- Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
- Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
- Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
- Impressive Data on Prognostic Importance of Lipids May Lead to Earlier Prescription in Those with High Long-Term ASCVD Risk EstimatesJanuary 2020
- Impressive Data on Prognostic Importance of Lipids May Lead to Earlier Prescription in Those with High Long-Term ASCVD Risk EstimatesJanuary 2020
- Reporting the Clinical Value of Cardiovascular Risk FactorsFebruary 2019
- Statin Safety and Adverse EventsDecember 2018
- New Data on Aspirin Use in the Era of More Widespread Statin UseSeptember 2018
- Astro-CHARM, the First 10-Year ASCVD Risk Estimator Incorporating Coronary CalciumAugust 2018
- Impact of C-reactive Protein and Coronary Artery Calcium on Benefit Observed with AtorvastatinMay 2018
- The Prognostic Value of High Sensitivity C-reactive Protein in a Multi-Ethnic Population After >10 Years of Follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA)May 2018
- 10-Year Resource Utilization and Costs for Cardiovascular CareMarch 2018
- Join now to see all
Press Mentions
- Blood Tests Can Help Predict Heart Disease Risk over Next 3 DecadesSeptember 5th, 2024
- Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV EventsAugust 31st, 2024
- Wait, Are People over 60 Supposed to Take Aspirin for Heart Health or Not?August 7th, 2024
- Join now to see all
Grant Support
- Cholesterol Lowering By Nurses To Control Heart DiseaseNational Center For Research Resources2000–2002
Research History
- Director, Johns Hopkins Ciccarone CenterOur research has focused on cost-effective ways to improve cardiovascular risk prediction and optimize patient-centered cardiac care. in the primary and secondary prevention settings.
Professional Memberships
- Fellow
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/roger-blumenthal
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: